Epithelium-on corneal cross-linking treatment of progressive keratoconus: a prospective, consecutive study

Epithelium-on corneal cross-linking treatment of progressive keratoconus: a prospective, consecutive study

PURPOSE To evaluate the outcome of collagen cross-linking (CXL) without corneal epithelial debridement in patients treated for progressive keratoconus for whom the standard epithelium-off treatment cannot be applied, as their central corneal thickness (CCT) is less than 400 μm. PATIENTS AND METHODS This was a prospective, uncontrolled, interventional study involving 32 eyes of 30 patients wit...

Primary Outcomes of Accelerated Epithelium-Off Corneal Cross-Linking in Progressive Keratoconus in Children: A 1-Year Prospective Study

Purpose To evaluate corneal transparency following accelerated collagen cross-linking (ACXL) in pediatric keratoconus. Design A prospective interventional case series. Methods This study included 47 eyes (25 patients), aged 9-14 years, with documented progressive keratoconus. After applying 0.1% riboflavin drops, ACXL was performed. Assessment included corrected distance visual acuity (CDVA...

“Epithelium-on” corneal collagen cross-linking in treatment of keratoconus – non randomized retrospective study

The 7-Year Outcomes of Epithelium-Off Corneal Cross-linking in Progressive Keratoconus.

PURPOSE To evaluate the clinical results of epitheliumoff corneal cross-linking (CXL) during a 7-year follow-up. METHODS This retrospective, non-randomized, single-center interventional study enrolled 34 consecutive eyes of 24 patients with progressive keratoconus undergoing CXL surgery with epithelium removal. Visual, refractive, corneal topographic, pachymetric, and anterior segment changes...

Corneal Cross-Linking for Progressive Keratoconus in Children: Our Experience

Purpose: To assess the effect of corneal cross-linking on progressive keratoconus in children. Method: In this retrospective study we enrolled nine eyes of nine consecutive children aged 11 to 17 years old who underwent corneal riboflavin-UVA induced cross-linking for progressive keratoconus at the Department of Ophthalmology at Assaf Harofeh Medical Center. They were followed for 6 to 24 month...